Color Doppler Analysıs Of Uterin And Intraovarian Blood Flow Before And After Treatment Wıth Cabergoline In Hyperprolactinemic Patients

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Status and phase: Completed; Phase 4

Conditions: Adverse Reaction to Other Drugs and Medicines

Treatments: Drug: cabergoline treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT01957839

OA8 (Other Identifier)

Aşıcıoğlu-08

Details and patient eligibility

About

the investigators examined the hypothesis that hyperprolactinemia may alter uterin, endometrial and intraovarian blood flow and may contribute to increased infertility by another way.

Enrollment: 48 patients

Sex: Female

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women who had blood prolactin level higher than 25ng/dl

Exclusion criteria

• Pregnancy
• Use of drugs effecting vasculature such as hormonal therapy, oral contraceptives, antihypertensives
• Diseases like pelvic inflammatory disease and systemic hypertension
• Women with clinically overt or treated cardiovascular disease
• Concurrent illness other than hyperprolactinemia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind

---

48 participants in 2 patient groups

pretreatment group

No Intervention group

Description:

doppler evaluation at pretreatment period

posttreatment group

Experimental group

Description:

doppler evaluatıon in normoprolactinemia women who given cabergoline treatment

Treatment:

Drug: cabergoline treatment